相关实验视频
Updated: Jul 5, 2026

03:57
Electrochemotherapy of Tumours
Published on: December 15, 2008
24.5K
用电化疗治疗癌复发:一个病例控制研究
Gregor Vivod1, Masa Omerzel2, Nina Kovacevic1
1Department of Gynecological Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Acta oncologica (Stockholm, Sweden)
|May 21, 2024
概括
电化学疗法 (ECT) 提供了与癌复发手术相比较的局部瘤控制. 这种创新的治疗方法,电化疗,也显著减少了住院和手术的持续时间,为非缓性病例提供了一个有希望的替代方案.
科学领域:
- 在瘤学瘤学.
- 手术瘤学手术瘤学
- 医疗技术 医疗技术 医学技术
背景情况:
- 癌复发通常需要手术,可能涉及广泛的切除.
- 电化学疗法 (ECT) 提供针对性癌细胞治疗,对健康组织的损害最小.
- 在复发的癌中,ECT为彻底手术提供了一种选择性的替代方案.
研究的目的:
- 为了比较电化学疗法 (ECT) 与非缓性癌复发的手术治疗的疗效和结果.
- 为了评估ECT和手术干预之间的局部瘤控制率.
- 评估ECT和手术治疗的手术持续时间和住院时间的差异.
主要方法:
- 一项涉及11名接受ECT治疗的患者和15名接受广泛局部切除治疗的患者的病例控制研究.
- 数据收集包括患者人口统计,瘤特征,治疗细节和住院时间.
- 进行了12个月的随访,以评估局部瘤控制.
主要成果:
- 在ECT和手术组之间,局部瘤控制的概率是相似的 (p = 0.694).
- 电脑心电疗法组在统计学上显著地显示出更短的平均住院时间和手术持续时间 (p < 0.001).
- 两组之间没有观察到患者特征或瘤因素的显著差异.
结论:
- 电化学疗法 (ECT) 是一种可行且有效的非息治疗性治疗,用于癌复发,与手术可比.
- 电脑心电疗法在减少住院和手术时间方面具有优势.
- 建议进行更大规模的随机试验,以证实在癌中用电化学治疗的这些发现.
更多相关视频
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...

